Nirsevimab 对在法国儿科重症监护病房住院的呼吸道合胞病毒毛细支气管炎的有效性 ,2023 年 9 月 - 2024 年 1 月。
关键词: bronchiolitis case–control studies immunisation monoclonal antibodies nirsevimab paediatric intensive care units respiratory syncytial virus treatment effectiveness
Mesh : Humans France / epidemiology Respiratory Syncytial Virus Infections / drug therapy Infant Intensive Care Units, Pediatric / statistics & numerical data Case-Control Studies Male Female Hospitalization / statistics & numerical data Respiratory Syncytial Virus, Human / drug effects Antibodies, Monoclonal, Humanized / therapeutic use Antiviral Agents / therapeutic use Bronchiolitis / drug therapy virology Bronchiolitis, Viral / drug therapy virology Treatment Outcome
来 源:
DOI:10.1111/irv.13311
PDF(Pubmed)